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Background. This paper aimed to identify condition-specific patient-reported outcome measures used in clinical trials among
people with wrist osteoarthritis and summarise empirical peer-reviewed evidence supporting their reliability, validity, and
responsiveness to change. Methods. A systematic review of randomised controlled trials among people with wrist osteoarthritis
was undertaken. Studies reporting reliability, validity, or responsiveness were identified using a systematic reverse citation
trail audit procedure. Psychometric properties of the instruments were examined against predefined criteria and summarised.
Results. Thirteen clinical trials met inclusion criteria. The most common patient-reported outcome was the disabilities of
the arm, shoulder, and hand questionnaire (DASH). The DASH, the Michigan Hand Outcomes Questionnaire (MHQ), the
Patient Evaluation Measure (PEM), and the Patient-Reported Wrist Evaluation (PRWE) had evidence supporting their reliability,
validity, and responsiveness. A post-hoc review of excluded studies revealed the AUSCAN Osteoarthritis Hand Index as another
suitable instrument that had favourable reliability, validity, and responsiveness. Conclusions. The DASH, MHQ, and AUSCAN
Osteoarthritis Hand Index instruments were supported by the most favourable empirical evidence for validity, reliability, and
responsiveness. The PEM and PRWE also had favourable empirical evidence reported for these elements. Further psychometric
testing of these instruments among people with wrist osteoarthritis is warranted.
1. Background
Wrist osteoarthritis is a common condition treated by upper
limb orthopaedic teams [1]. Clinical trials evaluating new
advances and ongoing refinement of intervention approaches
(both surgical and nonsurgical) for this clinical group require
the use of appropriate outcome measures to determine their
effect. Objective evaluation approaches such as radiographic
investigations and other measures of body function and
structure are central to this process [2]. However, patient-
reported outcomes consisting of questionnaire or rating scale
approaches are a valuable method of gaining quantitative
information about the lived experiences of people with the
condition [3]. Longitudinal use of patient-reported out-
comes over multiple assessment points can permit compar-
isons of pain, function, and health-related quality of life
within an individual over time, as well as comparisons
between groups of participants in clinical trials.
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The use of patient-reported outcomes as primary mea-
sures in clinical trials has become increasingly popular over
recent decades [4]. There are now multiple patient-reported
outcomes available for use in clinical trials for most ortho-
paedic conditions [5]. Some instruments are generic in
nature and include questions designed to summarise per-
ceived health in relation to broad life domains [3]. These
instruments are designed for use across a wide range of clin-
ical groups [3]. Two examples of generic instruments include
the Medical Outcomes Study 36-Item Short-Form Health
Survey (SF-36) and EuroQol-5D (EQ-5D) [6, 7]. There has
been considerable empirical research reporting favourable
measurement properties of these generic instruments [8–
21]. In summary, generic health-related quality of life instru-
ments capture multiple aspects of health-related quality of
life and can be particularly useful for making comparisons
of patient-reported health states across groups with hetero-
geneous clinical conditions [9, 12, 14, 15, 17, 18, 20, 22].
Pain scales are another group of patient-reported outcome
measures that have been widely used [23]. Comprehensive
critical analyses of pain evaluation approaches have been
reported previously [23–28]. In summary, there is evidence
to support the use of pain scales across a broad range of con-
ditions in clinical trials [23, 24, 26–28]. However, amongst
wrist osteoarthritis patients, the effects of the condition
extend beyond discomfort into areas of impairment and
activity limitation that can impact several key areas of func-
tioning and health-related quality of life.
The use of condition-specific instruments has great
potential for evaluating domains of physical functioning and
health-related quality of life commonly affected by a specific
pathology or body region dysfunction [22]. Condition-
specific instruments include questions focused on issues or
aspects of health that are commonly affected by the specific
condition or body region dysfunction that is under consid-
eration [3]. In the context of wrist osteoarthritis, condition-
specific patient-reported outcome measures can be used to
evaluate the impact of osteoarthritis on the upper limb, wrist
and hand functioning. Although the content of condition-
specific instruments may vary somewhat depending on
whether they focus on pathological symptoms or body
region functioning (or both), they share a common goal
of evaluating key elements of disability or health-related
quality of life relevant to wrist arthritis sufferers [29]. This
specific focus may enable these instruments to better reflect
changes relevant to wrist arthritis patients during clinical
trials evaluating the effects of targeted interventions [29,
30]. Similarly, it may reduce the chance of a treatment
effect being diluted among other health-related influences
(either positive or negative) that are not relevant to the
wrist osteoarthritis intervention under consideration during
randomised trials of clinical efficacy [30–32].
The selection of patient-reported outcomes for use in
clinical trials should be informed by empirical research sup-
porting several key instrument properties [33]. It is critical
that outcome measures used in clinical trials are reliable
and valid [3, 33–35]. Only guarded conclusions (at best)
can be drawn from patient assessments when uncertainty
exists regarding the reliability or validity of an assessment
instrument [3]. Additionally, it is also important that
patient-reported outcomes are responsive to change [36–
38]. An instrument that is not responsive to change is likely
to increase the chance of a false negative finding during a
clinical trial [39]. Such a finding would not only confound
the results of the clinical trial at hand, but potentially stifle
future research in the field.
Prior critical analyses examining the psychometric or
clinimetric properties of outcomemeasures with relevance to
orthopaedic upper limb patients have been undertaken [33–
35, 40, 41]. These reviews have included objective physical or
observational measures as well as patient-reported outcomes
evaluating symptoms, functioning, and participation in daily
activities across heterogeneous clinical groups. A systematic
review of disability measures for use in a population-based
survey of people with hand osteoarthritis has also been
reported [42]. However, there has been no prior review of
condition-specific patient-reported outcomes used in clinical
trials amongst patients with wrist osteoarthritis. The nature
of clinical interventions for wrist osteoarthritis differs from
other common conditions affecting the wrist or hand (such
as rheumatoid arthritis or acute tendon injuries). The pur-
pose of this paper is to report a systematic review examining
which condition-specific (or body region specific) patient-
reported outcomes have been used in clinical trials among
people with wrist osteoarthritis. This paper will identify
which instruments have been used and examine whether
they have evidence to support their validity, reliability, and
responsiveness. It is intended that this information will be
useful for informing instrument selection in future clinical
trials and highlighting priorities for future research in the
field.
The specific aims of this paper are therefore threefold:
first, to identify which condition-specific patient-reported
outcome measures have been used during randomised con-
trolled trials among people with wrist osteoarthritis; second,
to examine whether these instruments are supported by peer-
reviewed published empirical data reporting their reliability,
validity, or responsiveness, third, to discuss priorities for
future research to improve the quality of condition-specific
patient-reported outcomes for use in clinical trials.
2. Methods
2.1. Design. A systematic review of condition-specific
patient-reported outcome measures used in randomised tri-
als among people with wrist osteoarthritis was undertaken.
2.2. Search Strategy. Searches were performed in Medline,
National Institutes of Health online database, PubMed, and
CINAHL from the earliest records until the date of the search
(January 2012). Search terms included combinations of
terms (“wrist” or “carpal” or “radiocarpal”) and (“arthritis”
or “osteoarthritis”) and (“trial” or “RCT”). These terms were
used as keywords and expanded Medical Subject Headings
(MESH) terms to search all text. A conventional four-stage
screening approach to identify studies meeting the inclusion
and exclusion criteria was undertaken by two researchers
(Figure 1). A thirdmember of the research teamwas available
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to arbitrate any disagreement between the two researchers
but was not required. During the first stage duplicates were
removed. During the second stage, studies were screened
by title and non-relevant articles were removed. During the
third and fourth stages, articles were screened by abstract
and full text respectively, to examine whether articles met the
criteria of exclusion or inclusion with non-relevant articles
removed at each stage (Figure 1).
2.3. Study Selection
Inclusion and Exclusion. Manuscripts reporting randomised
clinical trials among adults with wrist osteoarthritis were
included. This included samples with arthritis affecting any
joint adjacent to the carpal bones (including trapeziom-
metacarpal joint). Studies that included participants with
osteoarthritis of other (non-carpal) joints in the hand or
elsewhere in the body were excluded. Studies among clinical
groups with other inflammatory arthritis such as rheumatoid
arthritis or juvenile arthritis were excluded. Manuscripts that
did not specify the type of arthritis present in their sample
were also excluded. There were no exclusion criteria based on
the intervention type or length of follow-up within the trial
as these factors were not under consideration in this paper.
2.4. Data Extraction and Instrument Property Assessment.
The population, interventions, and all outcome measures
used in each of the included studies were summarised
and tabulated (Table 1). Condition-specific patient-reported
outcome measures were identified and tabulated (Table 2). A
reverse citation trail audit was then undertaken to identify
published peer reviewed literature describing attributes
of reliability, validity, and responsiveness for each of the
patient-reported outcomes. This process involved identifying
the publication (or publications) in which the patient-
reported outcome was first reported (or the publication
which reported the appropriate version). This was deter-
mined through following the trail of citations for each instru-
ment included in the arthritis trials, back to the primary
source reporting the instrument. We termed this article
the “primary reference.” The authors considered it likely
that studies reporting reliability, validity, and responsiveness
for each of the instruments would have cited this primary
instrument publication. Citations for each primary reference
listed in Scopus, Pubmed, and Google Scholar were then
manually reviewed to determine which studies reported
components of reliability, validity, and responsiveness.
A summary of the elements of validity, reliability, and
responsiveness that have been reported for each of the instru-
ments were then tabulated (Table 3). Psychometric evalua-
tion of the identified measures was guided by established cri-
teria [63, 64], which are widely employed to assess the quality
of patient-reported outcome measures [65, 66]. With respect
to the aims of this study, we considered evidence for content
validity, construct validity, internal consistency, agreement
(absolute measurement error between repeated measures
expressed in unit of measurement of the scale), reliability
(reliability coefficients expressed as a ratio between 0 and
1), and responsiveness of each measure. The evidence was
Systematic review
Computer search results:
Medline (n = 200)
Pubmed (n = 242)
CINAHL (n = 572)
Total hits identified = 1014
Screen for duplicates
Retained: 733 articles
Titles screened
Retained: 172 articles
Abstracts screened
Retained: 22 articles
Full text screened
Final number included: 13 articles
Removed 281 duplicates
Excluded 561 articles
Excluded 150 articles
Excluded 9 articles
Figure 1: Search results and manuscripts excluded at each of the
four stages.
rated against predetermined criteria and classified into four
ratings (details of which are provided in the aforementioned
studies [63, 64], and a brief description of ratings is also
included below Table 3). To investigate whether less strict
study exclusion criteria would have resulted in the inclusion
of other high quality instruments (in terms of validity,
reliability, and responsiveness) a post-hoc examination of
outcome measures from studies excluded on the basis of
containing mixed diagnoses samples (rheumatoid arthritis
and wrist osteoarthritis) was also undertaken.
3. Results
3.1. Search Results. The searches returned a total of 1014
hits (Figure 1). This included 733 unique articles after the
removal of 281 duplicates. Screening by title then abstracts
removed a further 561 and 150 articles, respectively. Full
texts of the remaining 22 manuscripts were then retrieved
and a further 9 studies were excluded. Thirteen clinical trials
met all criteria and were included in the paper. Details of
the sample, the intervention under investigation, and the
outcome measures used in each of the thirteen studies are
outlined in Table 1. The inclusion of non-wrist osteoarthritis
or systemic conditions in the study sample was a common
reason for excluding clinical trials that were identified in the
searches.
3.2. Patient-Reported Outcomes. A total of 9 condition-spe-
cific patient-reported outcomes were used across the includ-
ed clinical trials (Table 2). Themost common patient-report-
ed outcome used in clinical trials for wrist osteoarthritis was
the disabilities of the arm, shoulder, and hand questionnaire
(DASH). The DASH was used in 4 of the 13 included
clinical trials. The hand function visual analogue scale (VAS)
was used in 3 clinical trials and the hand specific activities
of daily living (ADL) questionnaire was used in 2 clinical
trials. Six of the 9 condition-specific measures had been
used in only one clinical trial. One trial did not implement
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Table 1: Summary of the sample, intervention, and outcome measures used in included studies.
Author (year) Clinical population Intervention
Patient-reported
outcomes
Other measures
Nilsson et al. [43]
109 adults with painful
carpometacarpal OA∗
Surgical
implantation of
Artelon
carpometacarpal
joint spacer
Pain VAS∗
DASH∗ questionnaire
Strength: lateral and three-finger
pinch
ROM: thumb abduction
Bisneto et al. [44]
20 adults with wrist OA,
with a diagnosis of
scapholunate advanced
collapse (n = 4) or
scaphoid nonunion
advanced collapse
(n = 16)
Proximal row
carpectomy or
four-corner fusion
DASH questionnaire
Pain VAS
ROM∗: wrist flexion/extension,
radial/ulnar deviation,
pronation/supination
Strength: grip, pulp-pulp, lateral,
and three-finger pinch
Two-point discrimination: 2nd and
5th fingers, dorsum of 1st web
Hand and wrist volume
Jebson-Taylor functional test
Ritchie and Belcher [45]
41 adults with OA of the
trapeziometacarpal joint
Trapeziectomy
(anterior or
posterior approach)
ADL∗ questionnaire (10
items relating to hand
function)
Hand function VAS
Thumb pain VAS
Power VAS
Range of motion VAS
Cosmesis VAS
ROM: thumb joint including
opposition, palmar abduction, and
extension of trapeziometacarpal
joint
Strength: grip, thumb, and
three-finger pinch
Radiograph
Scar tenderness
Belcher and Nicholl [46]
36 adults (42 hands)
with OA of the
trapeziometacarpal joint
Trapeziectomy
(with/without
ligament
reconstruction and
tendon
interposition)
ADL∗ questionnaire
(10-items relating to
hand function)
Hand function VAS
Thumb pain VAS
Satisfaction with surgery
VAS
ROM: thumb interphalangeal,
metacarpophalangeal and
trapeziometacarpal joints
Strength: grip, thumb and three
finger pinch
Radiograph
Horlock and Belcher [47]
39 adults (40 hands)
with OA of the 1st
carpometacarpal joint
Early versus late
mobilisation
following simple
trapeziectomy
Hand function VAS
Thumb pain VAS
ROM: interphalangeal,
metacarpophalangeal and first
carpometacarpal joints
Strength: grip, thumb and three
finger pinch
Radiograph
Jain et al. [48]
62 adults (84 joints)
with painful OA of the
trapeziometacarpal joint
Transdermal
steroids
Michigan Hand
Outcomes
Questionnaire (MHQ)
Short form 12 (SF12)
Pain VAS
ROM: thumb hyperextension
Thumb adduction contractures
Strength: grip, tip-to-tip, and lateral
pinch
Fuchs et al. [49]
56 adults with OA of the
carpometacarpal joint
Intra-articular
injection (sodium
hyaluronate)
Pain VAS
Heat, swelling, and crepitations
under palpation
Strength: lateral and pulp pinch
ROM: radial and palmar
abduction/adduction, opposition
Davis et al. [50]
162 women (183
thumbs) with OA of the
trapeziometacarpal joint
Trapeziectomy —
Subjective measures of: thumb pain,
stiffness, and restriction of ADLs
Strength: grip, tip-to-tip and lateral
pinch
ROM: thumb joint, palmar and
radial abduction, opposition, and
hyperextension
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Table 1: Continued.
Author (year) Clinical population Intervention
Patient-reported
outcomes
Other measures
Kriegs-Au et al. [51]
43 adults (53 thumbs)
with OA of the thumb
carpometacarpal joint
Trapeziectomy with
ligament
reconstruction
(with/without
tendon
interposition)
Questionnaires relating
to pain, strength, daily
function, dexterity,
cosmetic appearance,
willingness to undergo
similar surgery, and
satisfaction with surgery
10-item questionnaire
relating to functional
tasks
Buck-Gramcko score
ROM: Palmar and radial abduction,
opposition, and hyperextension
Strength: grip and tip pinch
Radiograph
Weiss et al. [52]
25 adults with OA of the
carpometacarpal joint
Custom-made short
opponens
thermoplastic or
prefabricated short
neoprene splints
Pain severity/duration
VAS
Tip pinch pain VAS
22-item ADLs
questionnaire
Splint rating VAS
Strength: Tip pinch
Radiograph
Field et al. [53]
65 adults with OA of the
carpometacarpal joint
Trapeziectomy (with
or without flexor
carpi radialis
suspension)
Pain VAS
ROM: thumb joint, radial, and
palmer abduction, 1st web space
span
Strength: grip, three-finger and, tip
pinch
Radiograph
Procedure satisfaction
De Smet et al. [54]
56 females with painful
OA of the 1st
carpometacarpal joint
Trapeziectomy (with
or without tendon
interposition/
ligament
reconstruction)
Pain VAS
Pain relief questionnaire
DASH questionnaire
Functional outcome
questionnaire
ROM: all thumb joints, web angle
Strength: grip and three-finger
pinch
Radiograph
Davis and Pace [55]
113 adults (133 thumbs)
with OA of the
trapeziometacarpal joint
Trapeziectomy: with
ligament
reconstruction,
tendon
interposition, and
Kirschner wire
insertion followed
by splintage or with
no Kirschner wire
and immobilisation
in a soft bandage
Patient Evaluation
Measure (PEM)
DASH questionnaire
Thumb pain, strength, and stiffness
ROM: trapeziometacarpal joint
extension, palmar abduction,
opposition, and
metacarpophalangeal
hyperextension
Strength: grip, three-finger, and tip
pinch
∗
Abbreviations: OA: osteoarthritis, DASH: disabilities of the arm, shoulder and hand questionnaire, VAS: visual analogue scale, ROM: range of motion.
a condition-specific patient-reported outcome in addition to
other clinical measures such as pain, joint range of motion,
and muscle strength. Satisfaction and appearance were each
measured in one trial. Six instruments used a Likert scale for
measurement; the remaining 3 instruments used a VAS.
A concise summary of manuscripts reporting the reliabil-
ity, validity, and responsiveness of each of the 9 instruments
is outlined in Table 3. Four out of the 9 instruments had
empirical evidence reported for all elements of validity, relia-
bility, and responsiveness under consideration in this paper.
These were the DASH, MHQ, Patient Evaluation Measure
(PEM), and Patient-Rated Wrist Evaluation (PRWE). Three
instruments had no empirical studies reporting any compo-
nents of validity, reliability, or responsiveness. Instruments
with empirical evidence supporting content and construct
validity included the DASH, MHQ, and PRWE. Instruments
with empirical evidence supporting internal consistency,
agreement, and reliability included the DASH and MHQ.
Favourable responsiveness was also reported for the DASH,
MHQ, PEM, and PRWE. The post-hoc review included 3
additional studies that did not meet inclusion criteria due
to mixed rheumatoid arthritis and wrist osteoarthritis
diagnoses samples and led to the identification of one
additional outcome measure with favourable evidence sup-
porting its validity, reliability, and responsiveness [42, 67–
69]. This measure was the Australian/Canadian (AUSCAN)
Osteoarthritis Hand Index [42, 67–69].
4. Discussion
4.1. Main Finding. This investigation has identified 9 condi-
tion-specific patient-reported outcomes reported across
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Table 2: Characteristics of identified condition (or body region) specific patient reported outcomes.
Measure∧
Identified
studies citing
the measure
Primary
reference for
measure
Number of
unique citations
for the measure
Anatomical
region
Assesses
Number of items
(type)
Cosmesis visual analog scale (VAS) [45] None† None† Hand Appearance 1 (100mm VAS)
Disabilities of the arm, shoulder, and
hand (DASH)
[43, 44, 54, 55] [56] 1103 Upper limb
Symptoms,
function
30 (5-point Likert)
Hand function visual analog scale
(VAS)
[45–47] None† None† Hand Function 1 (100mm VAS)
Hand specific ADL questionnaire [45, 46] [57] 18 Hand Function 10 (4-Point Likert)
Michigan Hand Outcomes
Questionnaire (MHQ)
[48] [58] 196 Hand
Symptom,
function,
satisfaction
37 “core” items
(5-point Likert)
Patient Evaluation Measure (PEM) [55] [59] 71 Hand/wrist
Symptom,
function 10 (7-point Likert)
∗
Patient-Rated Wrist Evaluation
(PRWE)
[60] [61, 62] 210 Wrist/hand
Symptom,
function 15 (11-point Likert)
Perceived grip strength scale [53] None† None† Hand Function 1 (100mm VAS)
Scale of hand-specific activity
performance
[51] None† None† Hand Function 10 (5-point Likert)
∧
Each measure is patient-administered.
∗The total measure is comprised of 18 items; 10 of which form the Hand Health Profile.
†Trial did not cite a source for this measure. No article cited the trial-reported reliability, validity, or responsiveness of the instrument.
Table 3: Summary of quality ratings for identified measures.
Measure
Content
validity
Construct
validity
Internal
consistency
Interrater
agreement
Reliability Responsiveness
Cosmesis visual analog scale (VAS) ? ? ? ? ? ?
Disabilities of the arm, shoulder, and hand
questionnaire (DASH)
+ + + + + +
Hand function visual analog scale (VAS) ? ? ? ? ? ?
Hand-specific ADL questionnaire ? 0 0 ? ? ?
Michigan Hand Outcomes Questionnaire (MHQ) + + + + + +
Patient Evaluation Measure (PEM) 0 + + 0 + +
Patient-Rated Wrist Evaluation + + + 0 + +
Perceived grip strength scale ? ? ? ? ? ?
Scale of hand-specific activity performance ? ? ? ? ? ?
+: positive rating; 0: substantially conflicting results or methodology concerns (including unclear methodology description);−: negative rating (not required);
?: no/insufficient information.
Note: Psychometric testing of these measures among any clinical population with upper limb pathology was included.
13 clinical trials amongst patients with wrist osteoarthritis
(Table 1). Empirical evidence had been reported across all
categories of validity, reliability, and responsiveness for four
of these instruments (Table 2). The DASH and the MHQ
had the most favourable and comprehensive supporting
empirical evidence. The DASH was also the most commonly
used condition-specific patient-reported outcome in the
included clinical trials (Table 1). However, the PEM and
PRWE also generally had favourable empirical evidence
reported for elements of validity, reliability, and respon-
siveness. The AUSCAN Osteoarthritis Hand Index was also
identified as a potentially useful instrument with favourable
findings supporting its reliability, validity and responsiveness
from a post-hoc review of studies excluded due to mixed
rheumatoid and wrist osteoarthritis samples [42, 67–69].
Few investigations of validity, reliability, and responsive-
ness of these instruments included patients with osteoarthri-
tis (Table 2). The findings reported in Table 3 should there-
fore be interpreted with caveats. These outcome measures
have demonstrated reliability, validity, and responsiveness
among mixed clinical population groups with diagnoses
affecting the upper limb. An assertion that favourable meas-
urement properties would hold true among patients with
wrist osteoarthritis cannot be made with certainty. Nonethe-
less, in the absence of conflicting evidence, these empirical
studies lend weight to the argument that these instruments
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are likely to have favourable measurement properties when
used among people with wrist osteoarthritis participating in
clinical trials.
The selection of a patient-reported outcome for use in a
clinical trial should be informed by several factors in addition
to the measurement properties of the instrument [33]. Not
all condition-specific patient-reported outcomemeasures are
evaluating the same content or construct (Table 2). Similarly,
not all instruments will have used the same response format
(Table 2). These factors are important to consider when
designing clinical trials. Other potential sources of bias
beyond the scope of this paper may also influence the suit-
ability of instruments for use in a particular clinical trial [31,
32, 70]. For this reason the summary information reported
in this investigation is intended to be informative rather
than provide prescriptive recommendations regarding which
instruments should and should not be used.
4.2. Comparison to Prior Research. The findings of favourable
empirical psychometric data for the condition-specific
patient-reported outcomes (Table 3) reported in this study
are consistent with prior investigations of reliability, validity,
and responsiveness of patient-reported outcomes amongst
other orthopaedic patient groups [34, 40–42]. The post-
hoc identification of the AUSCAN Osteoarthritis Hand
Index as a relevant instrument with favourable psychometric
properties is also consistent with prior reviews that included
outcome measures for upper limb orthopaedic conditions
[40–42]. This lends weight to the assertion that the AUSCAN
Osteoarthritis Hand Index is also worthy of consideration
for future clinical trials amongst people with wrist arthritis
[42, 67, 68, 71–73].
4.3. Strengths and Limitations. The systematic audit trail
approach to identify potential empirical evidence to support
or refute the use of the patient-reported outcomes identified
in this papermay be considered both a strength andweakness
of this systematic review. A strength as it offers a systematic,
albeit time consuming, method to identify studies that have
reported elements of validity, reliability, and responsiveness.
On the other hand, this citation trail audit would not have
identified non-peer reviewed or unpublished sources of data
reporting these attributes. However, this approach suited
the aim of this investigation to review only published peer-
reviewed reports of this information.
A limitation to the extrapolation of study findings is
that study designs other than randomised controlled trials
were excluded. This approach was the most appropriate for
addressing the research question at hand that dealt specif-
ically with identifying instruments that have been used in
clinical trial environments. However, instruments used in
other contexts (such as population-based surveys) were not
included in the scope of this review.
4.4. Future Research. Findings from this investigation have
several key implications for future research. Future clinical
trials should consider the reliability, validity, and respon-
siveness of patient-reported outcomes under consideration
for inclusion in clinical trial assessments. The DASH, MHQ,
PEM, PRWE, and AUSCAN Osteoarthritis Hand Index all
have published peer-reviewed empirical evidence available
to inform this decision. Future research involving the other
instruments reported in this investigation (Table 2) should
consider exploring the properties (validity, reliability, and
responsiveness) not yet reported. Additionally, it would be
useful for future investigations involving wrist arthritis pop-
ulations to consider empirical work confirming or refuting
the measurement properties of the instruments included in
this paper with data obtained from patients suffering from
wrist arthritis.
5. Conclusions
This investigation identified a range of condition-specific
patient-reported outcome measures that have been used in
clinical trials amongst patients with wrist osteoarthritis. The
DASH was the most commonly used instrument across these
clinical trials. The DASH and MHQ both had consistent
favourable findings across all elements of validity, reliability,
and responsiveness under consideration. However, the PEM
and PRWE also generally had favourable empirical evidence
reported for elements of validity, reliability, and responsive-
ness. The AUSCAN Osteoarthritis Hand Index was not used
among trials meeting the strict inclusion criteria. However, it
was identified as another suitable instrument with favourable
reliability, validity, and responsiveness and is also worthy of
consideration for future clinical trials among people with
wrist osteoarthritis.
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